Skip to main content
PMC home page
The EMBO Journal logoLink to The EMBO Journal
. 1999 Jun 15;18(12):3334–3347. doi: 10.1093/emboj/18.12.3334

Activation of the erythropoietin receptor by the gp55-P viral envelope protein is determined by a single amino acid in its transmembrane domain.

S N Constantinescu 1, X Liu 1, W Beyer 1, A Fallon 1, S Shekar 1, Y I Henis 1, S O Smith 1, H F Lodish 1
PMCID: PMC1171414  PMID: 10369674

Abstract

The spleen focus forming virus (SFFV) gp55-P envelope glycoprotein specifically binds to and activates murine erythropoietin receptors (EpoRs) coexpressed in the same cell, triggering proliferation of erythroid progenitors and inducing erythroleukemia. Here we demonstrate specific interactions between the single transmembrane domains of the two proteins that are essential for receptor activation. The human EpoR is not activated by gp55-P but by mutation of a single amino acid, L238, in its transmembrane sequence to its murine counterpart serine, resulting in its ability to be activated. The converse mutation in the murine EpoR (S238L) abolishes activation by gp55-P. Computational searches of interactions between the membrane-spanning segments of murine EpoR and gp55-P provide a possible explanation: the face of the EpoR transmembrane domain containing S238 is predicted to interact specifically with gp55-P but not gp55-A, a variant which is much less effective in activating the murine EpoR. Mutational studies on gp55-P M390, which is predicted to interact with S238, provide additional support for this model. Mutation of M390 to isoleucine, the corresponding residue in gp55-A, abolishes activation, but the gp55-P M390L mutation is fully functional. gp55-P is thought to activate signaling by the EpoR by inducing receptor oligomerization through interactions involving specific transmembrane residues.

Full Text

The Full Text of this article is available as a PDF (456.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams P. D., Arkin I. T., Engelman D. M., Brünger A. T. Computational searching and mutagenesis suggest a structure for the pentameric transmembrane domain of phospholamban. Nat Struct Biol. 1995 Feb;2(2):154–162. doi: 10.1038/nsb0295-154. [DOI] [PubMed] [Google Scholar]
  2. Adams P. D., Engelman D. M., Brünger A. T. Improved prediction for the structure of the dimeric transmembrane domain of glycophorin A obtained through global searching. Proteins. 1996 Nov;26(3):257–261. doi: 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
  3. Amanuma H., Katori A., Obata M., Sagata N., Ikawa Y. Complete nucleotide sequence of the gene for the specific glycoprotein (gp55) of Friend spleen focus-forming virus. Proc Natl Acad Sci U S A. 1983 Jul;80(13):3913–3917. doi: 10.1073/pnas.80.13.3913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Amanuma H., Watanabe N., Nishi M., Ikawa Y. Requirement of the single base insertion at the 3' end of the env-related gene of Friend spleen focus-forming virus for pathogenic activity and its effect on localization of the glycoprotein product (gp55). J Virol. 1989 Nov;63(11):4824–4833. doi: 10.1128/jvi.63.11.4824-4833.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bargmann C. I., Hung M. C., Weinberg R. A. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell. 1986 Jun 6;45(5):649–657. doi: 10.1016/0092-8674(86)90779-8. [DOI] [PubMed] [Google Scholar]
  6. Burke C. L., Lemmon M. A., Coren B. A., Engelman D. M., Stern D. F. Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation. Oncogene. 1997 Feb 13;14(6):687–696. doi: 10.1038/sj.onc.1200873. [DOI] [PubMed] [Google Scholar]
  7. Chung S. W., Wolff L., Ruscetti S. K. Transmembrane domain of the envelope gene of a polycythemia-inducing retrovirus determines erythropoietin-independent growth. Proc Natl Acad Sci U S A. 1989 Oct;86(20):7957–7960. doi: 10.1073/pnas.86.20.7957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Constantinescu S. N., Wu H., Liu X., Beyer W., Fallon A., Lodish H. F. The anemic Friend virus gp55 envelope protein induces erythroid differentiation in fetal liver colony-forming units-erythroid. Blood. 1998 Feb 15;91(4):1163–1172. [PubMed] [Google Scholar]
  9. Cosson P., Bonifacino J. S. Role of transmembrane domain interactions in the assembly of class II MHC molecules. Science. 1992 Oct 23;258(5082):659–662. doi: 10.1126/science.1329208. [DOI] [PubMed] [Google Scholar]
  10. D'Andrea A. D., Lodish H. F., Wong G. G. Expression cloning of the murine erythropoietin receptor. Cell. 1989 Apr 21;57(2):277–285. doi: 10.1016/0092-8674(89)90965-3. [DOI] [PubMed] [Google Scholar]
  11. Drummond-Barbosa D., DiMaio D. Virocrine transformation. Biochim Biophys Acta. 1997 Feb 22;1332(1):M1–17. doi: 10.1016/s0304-419x(96)00034-0. [DOI] [PubMed] [Google Scholar]
  12. Elliott S., Lorenzini T., Yanagihara D., Chang D., Elliott G. Activation of the erythropoietin (EPO) receptor by bivalent anti-EPO receptor antibodies. J Biol Chem. 1996 Oct 4;271(40):24691–24697. doi: 10.1074/jbc.271.40.24691. [DOI] [PubMed] [Google Scholar]
  13. FRIEND C. Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J Exp Med. 1957 Apr 1;105(4):307–318. doi: 10.1084/jem.105.4.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ferro F. E., Jr, Kozak S. L., Hoatlin M. E., Kabat D. Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus. J Biol Chem. 1993 Mar 15;268(8):5741–5747. [PubMed] [Google Scholar]
  15. Furthmayr H., Marchesi V. T. Subunit structure of human erythrocyte glycophorin A. Biochemistry. 1976 Mar 9;15(5):1137–1144. doi: 10.1021/bi00650a028. [DOI] [PubMed] [Google Scholar]
  16. Gliniak B. C., Kozak S. L., Jones R. T., Kabat D. Disulfide bonding controls the processing of retroviral envelope glycoproteins. J Biol Chem. 1991 Dec 5;266(34):22991–22997. [PubMed] [Google Scholar]
  17. Han M., Smith S. O., Sakmar T. P. Constitutive activation of opsin by mutation of methionine 257 on transmembrane helix 6. Biochemistry. 1998 Jun 2;37(22):8253–8261. doi: 10.1021/bi980147r. [DOI] [PubMed] [Google Scholar]
  18. Harbury P. B., Zhang T., Kim P. S., Alber T. A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science. 1993 Nov 26;262(5138):1401–1407. doi: 10.1126/science.8248779. [DOI] [PubMed] [Google Scholar]
  19. Henis Y. I., Moustakas A., Lin H. Y., Lodish H. F. The types II and III transforming growth factor-beta receptors form homo-oligomers. J Cell Biol. 1994 Jul;126(1):139–154. doi: 10.1083/jcb.126.1.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hoatlin M. E., Ferro F. E., Jr, Geib R. W., Fox M. T., Kozak S. L., Kabat D. Deletions in one domain of the Friend virus-encoded membrane glycoprotein overcome host range restrictions for erythroleukemia. J Virol. 1995 Feb;69(2):856–863. doi: 10.1128/jvi.69.2.856-863.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hoatlin M. E., Kabat D. Host-range control of a retroviral disease: Friend erythroleukemia. Trends Microbiol. 1995 Feb;3(2):51–57. doi: 10.1016/s0966-842x(00)88875-7. [DOI] [PubMed] [Google Scholar]
  22. Ihle J. N., Witthuhn B. A., Quelle F. W., Yamamoto K., Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol. 1995;13:369–398. doi: 10.1146/annurev.iy.13.040195.002101. [DOI] [PubMed] [Google Scholar]
  23. Jones S. S., D'Andrea A. D., Haines L. L., Wong G. G. Human erythropoietin receptor: cloning, expression, and biologic characterization. Blood. 1990 Jul 1;76(1):31–35. [PubMed] [Google Scholar]
  24. Kabat D. Molecular biology of Friend viral erythroleukemia. Curr Top Microbiol Immunol. 1989;148:1–42. doi: 10.1007/978-3-642-74700-7_1. [DOI] [PubMed] [Google Scholar]
  25. Lemmon M. A., Treutlein H. R., Adams P. D., Brünger A. T., Engelman D. M. A dimerization motif for transmembrane alpha-helices. Nat Struct Biol. 1994 Mar;1(3):157–163. doi: 10.1038/nsb0394-157. [DOI] [PubMed] [Google Scholar]
  26. Li J. P., D'Andrea A. D., Lodish H. F., Baltimore D. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature. 1990 Feb 22;343(6260):762–764. doi: 10.1038/343762a0. [DOI] [PubMed] [Google Scholar]
  27. Li J. P., Hu H. O., Niu Q. T., Fang C. Cell surface activation of the erythropoietin receptor by Friend spleen focus-forming virus gp55. J Virol. 1995 Mar;69(3):1714–1719. doi: 10.1128/jvi.69.3.1714-1719.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Linemeyer D. L., Menke J. G., Ruscetti S. K., Evans L. H., Scolnick E. M. Envelope gene sequences which encode the gp52 protein of spleen focus-forming virus are required for the induction of erythroid cell proliferation. J Virol. 1982 Jul;43(1):223–233. doi: 10.1128/jvi.43.1.223-233.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Liu X., Sun Y., Constantinescu S. N., Karam E., Weinberg R. A., Lodish H. F. Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10669–10674. doi: 10.1073/pnas.94.20.10669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Livnah O., Stura E. A., Johnson D. L., Middleton S. A., Mulcahy L. S., Wrighton N. C., Dower W. J., Jolliffe L. K., Wilson I. A. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science. 1996 Jul 26;273(5274):464–471. doi: 10.1126/science.273.5274.464. [DOI] [PubMed] [Google Scholar]
  31. Livnah O., Stura E. A., Middleton S. A., Johnson D. L., Jolliffe L. K., Wilson I. A. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science. 1999 Feb 12;283(5404):987–990. doi: 10.1126/science.283.5404.987. [DOI] [PubMed] [Google Scholar]
  32. Longmore G. D., Lodish H. F. An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: a cytokine receptor superfamily oncogene. Cell. 1991 Dec 20;67(6):1089–1102. doi: 10.1016/0092-8674(91)90286-8. [DOI] [PubMed] [Google Scholar]
  33. Longmore G. D., Pharr P., Lodish H. F. Mutation in murine erythropoietin receptor induces erythropoietin-independent erythroid proliferation in vitro, polycythemia in vivo. Leukemia. 1992;6 (Suppl 3):130S–134S. [PubMed] [Google Scholar]
  34. Longmore G. D., Pharr P., Neumann D., Lodish H. F. Both megakaryocytopoiesis and erythropoiesis are induced in mice infected with a retrovirus expressing an oncogenic erythropoietin receptor. Blood. 1993 Oct 15;82(8):2386–2395. [PubMed] [Google Scholar]
  35. MacDonald M. E., Reynolds F. H., Jr, Van de Ven W. J., Stephenson J. R., Mak T. W., Bernstein A. Anemia- and polycythemia-inducing isolates of Friend spleen focus-forming virus. Biological and molecular evidence for two distinct viral genomes. J Exp Med. 1980 Jun 1;151(6):1477–1492. doi: 10.1084/jem.151.6.1477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. MacKenzie K. R., Prestegard J. H., Engelman D. M. A transmembrane helix dimer: structure and implications. Science. 1997 Apr 4;276(5309):131–133. doi: 10.1126/science.276.5309.131. [DOI] [PubMed] [Google Scholar]
  37. Manolios N., Bonifacino J. S., Klausner R. D. Transmembrane helical interactions and the assembly of the T cell receptor complex. Science. 1990 Jul 20;249(4966):274–277. doi: 10.1126/science.2142801. [DOI] [PubMed] [Google Scholar]
  38. Mirand E. A., Steeves R. A., Lange R. D., Grace J. T., Jr Virus-induced polycythemia in mice: erythropoiesis without erythropoietin. Proc Soc Exp Biol Med. 1968 Jul;128(3):844–849. doi: 10.3181/00379727-128-33139. [DOI] [PubMed] [Google Scholar]
  39. Moreau-Gachelin F., Ray D., de Both N. J., van der Feltz M. J., Tambourin P., Tavitian A. Spi-1 oncogene activation in Rauscher and Friend murine virus-induced acute erythroleukemias. Leukemia. 1990 Jan;4(1):20–23. [PubMed] [Google Scholar]
  40. Nilges M., Brünger A. T. Successful prediction of the coiled coil geometry of the GCN4 leucine zipper domain by simulated annealing: comparison to the X-ray structure. Proteins. 1993 Feb;15(2):133–146. doi: 10.1002/prot.340150205. [DOI] [PubMed] [Google Scholar]
  41. Pear W. S., Nolan G. P., Scott M. L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8392–8396. doi: 10.1073/pnas.90.18.8392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Petti L. M., Reddy V., Smith S. O., DiMaio D. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein. J Virol. 1997 Oct;71(10):7318–7327. doi: 10.1128/jvi.71.10.7318-7327.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Quang C. T., Wessely O., Pironin M., Beug H., Ghysdael J. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation. EMBO J. 1997 Sep 15;16(18):5639–5653. doi: 10.1093/emboj/16.18.5639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Remy I., Wilson I. A., Michnick S. W. Erythropoietin receptor activation by a ligand-induced conformation change. Science. 1999 Feb 12;283(5404):990–993. doi: 10.1126/science.283.5404.990. [DOI] [PubMed] [Google Scholar]
  45. Rousseau F., Bonaventure J., Legeai-Mallet L., Pelet A., Rozet J. M., Maroteaux P., Le Merrer M., Munnich A. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 1994 Sep 15;371(6494):252–254. doi: 10.1038/371252a0. [DOI] [PubMed] [Google Scholar]
  46. Ruscetti S. K., Feild J. A., Scolnick E. M. Polycythaemia- and anaemia-inducing strains of spleen focus-forming virus differ in post-translational processing of envelope-related glycoproteins. Nature. 1981 Dec 17;294(5842):663–665. doi: 10.1038/294663a0. [DOI] [PubMed] [Google Scholar]
  47. Semenza G. L., Dureza R. C., Traystman M. D., Gearhart J. D., Antonarakis S. E. Human erythropoietin gene expression in transgenic mice: multiple transcription initiation sites and cis-acting regulatory elements. Mol Cell Biol. 1990 Mar;10(3):930–938. doi: 10.1128/mcb.10.3.930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Shiang R., Thompson L. M., Zhu Y. Z., Church D. M., Fielder T. J., Bocian M., Winokur S. T., Wasmuth J. J. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 1994 Jul 29;78(2):335–342. doi: 10.1016/0092-8674(94)90302-6. [DOI] [PubMed] [Google Scholar]
  49. Showers M. O., DeMartino J. C., Saito Y., D'Andrea A. D. Fusion of the erythropoietin receptor and the Friend spleen focus-forming virus gp55 glycoprotein transforms a factor-dependent hematopoietic cell line. Mol Cell Biol. 1993 Feb;13(2):739–748. doi: 10.1128/mcb.13.2.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Socolovsky M., Dusanter-Fourt I., Lodish H. F. The prolactin receptor and severely truncated erythropoietin receptors support differentiation of erythroid progenitors. J Biol Chem. 1997 May 30;272(22):14009–14012. doi: 10.1074/jbc.272.22.14009. [DOI] [PubMed] [Google Scholar]
  51. Surti T., Klein O., Aschheim K., DiMaio D., Smith S. O. Structural models of the bovine papillomavirus E5 protein. Proteins. 1998 Dec 1;33(4):601–612. [PubMed] [Google Scholar]
  52. Syed R. S., Reid S. W., Li C., Cheetham J. C., Aoki K. H., Liu B., Zhan H., Osslund T. D., Chirino A. J., Zhang J. Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature. 1998 Oct 1;395(6701):511–516. doi: 10.1038/26773. [DOI] [PubMed] [Google Scholar]
  53. Tambourin P. E., Wendling F., Jasmin C., Smadja-Joffe F. The physiopathology of Friend leukemia. Leuk Res. 1979;3(3):117–129. doi: 10.1016/0145-2126(79)90009-2. [DOI] [PubMed] [Google Scholar]
  54. Tarr K., Watowich S. S., Longmore G. D. Cell surface organization of the erythropoietin receptor complex differs depending on its mode of activation. J Biol Chem. 1997 Apr 4;272(14):9099–9107. doi: 10.1074/jbc.272.14.9099. [DOI] [PubMed] [Google Scholar]
  55. Treutlein H. R., Lemmon M. A., Engelman D. M., Brünger A. T. The glycophorin A transmembrane domain dimer: sequence-specific propensity for a right-handed supercoil of helices. Biochemistry. 1992 Dec 29;31(51):12726–12732. doi: 10.1021/bi00166a003. [DOI] [PubMed] [Google Scholar]
  56. Watanabe N., Nishi M., Ikawa Y., Amanuma H. A deletion in the Friend spleen focus-forming virus env gene is necessary for its product (gp55) to be leukemogenic. J Virol. 1990 Jun;64(6):2678–2686. doi: 10.1128/jvi.64.6.2678-2686.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Watanabe N., Yugawa T., Ikawa Y., Amanuma H. Both the changes of six amino acids and the C-terminal truncation caused by a one-base insertion in the defective env gene of Friend spleen focus-forming virus significantly affect the pathogenic activity of the encoded leukemogenic membrane glycoprotein (gp55). J Virol. 1995 Dec;69(12):7606–7611. doi: 10.1128/jvi.69.12.7606-7611.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Watowich S. S., Hilton D. J., Lodish H. F. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol Cell Biol. 1994 Jun;14(6):3535–3549. doi: 10.1128/mcb.14.6.3535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Watowich S. S., Wu H., Socolovsky M., Klingmuller U., Constantinescu S. N., Lodish H. F. Cytokine receptor signal transduction and the control of hematopoietic cell development. Annu Rev Cell Dev Biol. 1996;12:91–128. doi: 10.1146/annurev.cellbio.12.1.91. [DOI] [PubMed] [Google Scholar]
  60. Watowich S. S., Yoshimura A., Longmore G. D., Hilton D. J., Yoshimura Y., Lodish H. F. Homodimerization and constitutive activation of the erythropoietin receptor. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2140–2144. doi: 10.1073/pnas.89.6.2140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Webster M. K., Donoghue D. J. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 1996 Feb 1;15(3):520–527. [PMC free article] [PubMed] [Google Scholar]
  62. Wolff L., Ruscetti S. Malignant transformation of erythroid cells in vivo by introduction of a nonreplicating retrovirus vector. Science. 1985 Jun 28;228(4707):1549–1552. doi: 10.1126/science.2990034. [DOI] [PubMed] [Google Scholar]
  63. Wrighton N. C., Farrell F. X., Chang R., Kashyap A. K., Barbone F. P., Mulcahy L. S., Johnson D. L., Barrett R. W., Jolliffe L. K., Dower W. J. Small peptides as potent mimetics of the protein hormone erythropoietin. Science. 1996 Jul 26;273(5274):458–464. doi: 10.1126/science.273.5274.458. [DOI] [PubMed] [Google Scholar]
  64. Wu H., Liu X., Jaenisch R., Lodish H. F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 1995 Oct 6;83(1):59–67. doi: 10.1016/0092-8674(95)90234-1. [DOI] [PubMed] [Google Scholar]
  65. Yoshimura A., D'Andrea A. D., Lodish H. F. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4139–4143. doi: 10.1073/pnas.87.11.4139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Yoshimura A., Longmore G., Lodish H. F. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature. 1990 Dec 13;348(6302):647–649. doi: 10.1038/348647a0. [DOI] [PubMed] [Google Scholar]
  67. Zon L. I., Moreau J. F., Koo J. W., Mathey-Prevot B., D'Andrea A. D. The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein. Mol Cell Biol. 1992 Jul;12(7):2949–2957. doi: 10.1128/mcb.12.7.2949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. de Vos A. M., Ultsch M., Kossiakoff A. A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 1992 Jan 17;255(5042):306–312. doi: 10.1126/science.1549776. [DOI] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES